https://www.vistaar.ai/blogs/ 2026-07-07T05:52:57+00:00 https://www.vistaar.ai/blog/usa-canada-uk-eu-approved-product-labels-aug-2022/ 2024-06-05T09:26:25+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/medical-device-regulatory-product-intelligence/ 2024-06-05T09:26:43+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/danish-medicines-agency-recommended-new-regulation-for-application-for-a-clinical-trial-permit-for-medical-devices/ 2024-06-05T09:31:30+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/building-regulatory-capacity-best-practices-for-the-future/ 2024-06-05T09:32:31+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/australia-tga-implemented-the-risk-based-approach-surrounding-fecal-microbiota-transplants/ 2024-06-05T09:32:45+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Diagnostics-min.jpg https://www.vistaar.ai/blog/danish-medicines-agency-newly-improved-reporting-requirement-to-strengthen-the-surveillance-of-medical-devices/ 2024-06-05T09:33:17+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/uncertainty-as-a-factor-in-determining-benefit-risk-for-pre-market-approval-of-medical-devices/ 2024-06-05T09:34:32+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/usa-fda-drafts-guidance-on-patient-engagement-in-device-trials/ 2024-06-05T09:35:10+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/why-is-medical-technology-getting-shrouded-by-the-fear-of-cybersecurity-issues/ 2024-06-05T09:35:24+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-device-change-control-process/ 2024-06-05T09:36:24+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-device-incident-and-adverse-event-reporting-timelines-in-6-major-markets/ 2024-06-05T09:36:30+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/regulatory-cmc-changes-challenges-and-management/ 2024-06-05T09:38:06+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/drug-regulatory-authority-of-pakistan-drap-establishing-regulatory-pathway-for-licensing-system-a-progressive-approach/ 2024-06-05T09:38:32+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/european-medicines-agency-seeks-public-opinion-on-draft-guideline-on-quality-requirements-for-medical-devices/ 2024-06-05T09:38:50+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/fda-bans-electrical-stimulation-devices-used-for-self-injurious-behavior-or-aggressive-behaviour/ 2024-06-05T09:39:02+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/fda-issues-guidances-on-dual-510k-and-clia-waiver-applications/ 2024-06-05T09:39:04+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/fda-launches-new-interactive-510k-template-program/ 2024-06-05T09:39:08+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/regulatory-challenges-for-combination-products/ 2024-06-05T12:58:43+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/fda-drafts-guidance-for-regulatory-submissions-in-alternate-electronic-format/ 2024-06-06T04:05:50+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/tmda-released-guidance-on-the-import-of-research-products-to-be-used-in-clinical-research/ 2024-06-06T04:07:07+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/usa-fda-revises-guidance-on-post-marketing-studies-and-clinical-trials/ 2024-06-06T04:09:13+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/labeling-requirements-for-prescription-drugs/ 2024-06-06T04:20:11+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Digital-Health.jpg https://www.vistaar.ai/blog/european-medicines-agency-issued-electronic-certificates-for-medicines/ 2024-06-06T04:24:39+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/european-medicines-agency-explanatory-note-on-implementation-of-ich-q12-guideline/ 2024-06-06T04:24:50+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/brazilgeneral-provisions-for-stability-studies-of-active-pharmaceuticals-and-medicines/ 2024-06-06T04:26:48+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/usa-fda-modifies-list-of-standards-for-premarket-device-reviews/ 2024-06-06T04:27:53+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/china-nmpa-joins-imdrfs-post-market-device-safety-data-exchange-scheme/ 2024-06-06T04:29:39+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/anvisa-updates-importation-law-key-changes/ 2024-06-06T04:34:00+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/vistaar-regulatory-intelligence/ 2024-06-06T04:41:17+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/fda-mhra-continues-to-facilitate-access-to-ventilators-supply/ 2024-06-06T04:52:22+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Food-1.jpg https://www.vistaar.ai/blog/tga-issues-new-guidance-for-tgo-101-standard-for-tablets-capsules-and-pills/ 2024-06-06T04:53:06+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/labeling-requirements-for-medical-devices/ 2024-07-01T05:50:52+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/chinas-cmde-announces-new-regulations-on-the-supervision-and-administration-of-customized-medical-devices-for-clinical-trials/ 2024-07-01T05:53:27+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/clinical-intelligence-for-better-clinical-trials/ 2024-07-01T06:02:45+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Diagnostics-min.jpg https://www.vistaar.ai/blog/regulatory-intelligence-is-a-key-to-quality-and-safety/ 2024-07-01T06:03:45+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/labeling-and-ifu-compliance-soon-to-follow-eu-mdr-transition/ 2024-07-01T06:05:26+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/OTC.jpg https://www.vistaar.ai/blog/eu-regulations-things-still-to-be-known/ 2024-07-01T06:05:40+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-device-labeling-under-fda/ 2024-07-01T06:07:03+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/fda-warning-letter-jan-apr-2021-recap-summary/ 2024-07-01T06:09:36+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/serotonergic-anti-depressants-for-depression-in-pregnant-women/ 2024-07-01T06:13:07+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/tgas-reclassification-of-medical-devices-around-the-corner-ready/ 2024-07-01T06:15:18+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/ich-guideline-on-testing-for-carcinogenicity-of-pharmaceuticals-an-addendum/ 2024-07-01T06:21:45+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/china-notice-on-registration-of-medical-device-master-files-no-2-of-2021/ 2024-07-01T06:29:09+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/switch-of-the-legal-status-of-a-medicinal-product-from-prescription-to-non-prescription-romania/ 2024-07-01T06:43:09+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/ich-guideline-e8-r1-on-general-considerations-for-clinical-studies/ 2024-07-01T06:46:25+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/artificial-intelligence-based-regulatory-intelligence-database/ 2024-07-01T07:00:49+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Digital-Health.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-news-jan-2023/ 2024-07-01T08:47:57+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/regulatory-reporting-software/ 2024-07-01T08:53:58+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-news-feb-2023/ 2024-07-01T08:54:17+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-march-2023-vol-1/ 2024-07-01T08:58:06+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/maximizing-success-and-mitigating-risk-the-strategic-role-of-pharma-regulatory-intelligence-database-in-the-pharmaceutical-industry/ 2024-07-01T09:35:18+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/regulatory-reporting-software-challenges-and-opportunities/ 2024-07-01T09:36:54+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-news-may-2023/ 2024-07-01T09:37:20+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/ai-transformation-of-regulatory-intelligence-in-pharma/ 2024-07-01T09:43:49+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/how-regulatory-tracking-software-can-help-pharma-companies-to-manage-risk/ 2024-07-01T09:46:09+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Digital-Health.jpg https://www.vistaar.ai/blog/regulatory-database-a-boon-to-the-manufacturers/ 2024-07-01T09:48:24+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/anvisa-new-medical-device-regulation-rdc-751-2022/ 2024-07-01T09:50:01+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/regulatory-intelligence-shows-path-to-the-success-in-pharma-industry/ 2024-07-01T09:52:16+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/pharma-regulatory-intelligence-tools-and-supply-chain-management/ 2024-07-01T09:54:55+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/artificial-intelligence-in-drug-discovery-and-development/ 2024-07-01T09:55:57+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Digital-Health.jpg https://www.vistaar.ai/blog/usfda-latest-fee-summary-table-for-drugs-and-devices/ 2024-07-01T09:59:34+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/the-role-of-regulatory-tracking-software-in-accelerating-drug-approval-processes/ 2024-07-01T10:00:34+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Digital-Health.jpg https://www.vistaar.ai/blog/new-developments-in-treatment-of-rare-diseases/ 2024-07-01T10:07:16+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Digital-Health.jpg https://www.vistaar.ai/blog/consumer-health-usa-uk-asia-and-row-regulatory-news-aug-2024/ 2024-09-04T09:58:11+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/why-a-cosmetics-ingredients-database-is-essential-for-regulatory-compliance/ 2024-09-11T06:33:04+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg https://www.vistaar.ai/blog/medical-device-regulatory-challenges-solutions-expert-insights/ 2024-09-13T09:17:19+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/guide-to-consumer-health-ingredients-database-for-regulatory-compliance/ 2024-09-23T09:32:13+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/navigating-cosmetic-regulations-guide-to-compliance-with-global-standards/ 2024-09-30T09:23:10+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg https://www.vistaar.ai/blog/understanding-global-cosmetics-testing-requirements-a-comprehensive-guide/ 2024-09-30T09:30:21+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg https://www.vistaar.ai/blog/fda-issues-new-enforcement-policy-for-sterilizers-disinfectant-devices-and-air-purifiers-during-covid-19-emergency/ 2024-10-28T08:36:18+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/key-features-to-consider-in-regulatory-intelligence-software-for-2025/ 2024-11-04T05:44:46+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/utilizing-regulatory-intelligence-software-in-risk-management-and-compliance/ 2024-11-11T10:16:25+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-oct-2024/ 2024-11-18T10:29:25+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/cosmetics-testing-requirements-in-emerging-markets-opportunities-and-regulations/ 2024-11-21T10:17:08+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg https://www.vistaar.ai/blog/the-crucial-role-of-regulatory-impact-assessment-in-shaping-effective-policies/ 2024-12-06T07:05:47+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/reclassification-of-spinal-implantable-medical-devices/ 2025-02-19T09:42:42+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/expanded-otc-approvals-and-market-projections-2000-2040/ 2025-02-26T09:17:37+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/OTC.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-feb-2025/ 2025-03-11T08:32:50+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/regulatory-intelligence-database-software-tools-for-compliance/ 2025-03-26T07:35:49+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/fda-labeling-requirements-everything-you-need-to-know/ 2025-03-26T07:36:04+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/OTC.jpg https://www.vistaar.ai/blogs/standards-updates-for-last-6-months/ 2025-03-26T07:36:17+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/wp-content/uploads/2025/01/Banner-for-blog-resized.jpg https://www.vistaar.ai/blog/streamlining-global-market-access-with-medical-device-registration/ 2025-03-26T07:36:28+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/best-practices-for-effective-regulatory-requirements-monitoring/ 2025-03-26T07:36:40+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/leveraging-pharma-regulatory-intelligence-tools-for-global-market-access/ 2025-03-26T07:42:38+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/why-cosmetics-ingredients-database-is-essential-for-product-development/ 2025-03-27T04:05:17+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg https://www.vistaar.ai/blog/streamline-regulatory-compliance-with-an-intelligent-document-database/ 2025-04-02T10:19:30+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/top-features-to-look-for-in-a-regulatory-tracking-software/ 2025-04-03T05:37:02+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/fda-eu-and-asian-cosmetics-testing-requirements-a-comparative-analysis/ 2025-04-03T06:24:24+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-mar-2025/ 2025-04-08T05:28:01+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/cybersecurity-in-medical-devices-protecting-patient-data-and-ensuring-safety/ 2025-04-15T04:57:35+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-asia-s-america-mena-row-regulatory-news-march-2025/ 2025-04-15T10:04:33+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/regulatory-compliance-databases-and-tracking-the-complete-guide/ 2025-04-16T06:04:13+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/decode-cosmetic-labels-using-ingredients-databases/ 2025-05-02T11:28:57+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg https://www.vistaar.ai/blog/consumer-health-usa-s-america-asia-and-row-regulatory-news-mar-2025/ 2025-05-02T11:33:20+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/pharma-asia-s-america-mena-row-regulatory-news-april-2025/ 2025-05-06T12:36:55+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/consumer-usa-europe-asia-and-row-regulatory-news-april-2025/ 2025-05-07T07:24:10+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/pharmaceutical-regulatory-affairs-market-trends-and-forecast-2025-2030/ 2025-05-08T06:13:17+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/global-medical-packaging-pcr-recycling-regulations-a-country-wise-guide/ 2025-05-08T06:13:33+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-europe-uk-and-asia-regulatory-news-april-2025/ 2025-05-13T09:23:46+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-may-2025/ 2025-06-04T10:37:16+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/consumer-health-usa-europe-asia-and-row-regulatory-news-may-2025/ 2025-06-04T10:45:26+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/pharma-asia-s-america-mena-row-regulatory-news-may-2025/ 2025-06-10T06:54:42+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/regulatory-intelligence-auto-impacts-with-ai/ 2025-06-18T05:21:40+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/how-real-time-regulatory-intelligence-improves-compliance/ 2025-06-26T08:10:59+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-june-2025/ 2025-07-14T06:01:06+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/consumer-health-usa-asia-and-row-regulatory-news-june-2025/ 2025-07-14T06:01:16+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/pharma-asia-mena-row-regulatory-news-june-2025/ 2025-07-14T06:01:26+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/how-regulatory-intelligence-solutions-simplify-global-compliance/ 2025-07-31T07:30:22+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/medical-devices-europe-asia-and-row-regulatory-news-july-2025/ 2025-08-05T10:22:04+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-asia-s-america-mena-row-regulatory-news-july-2025/ 2025-08-06T09:50:12+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/pharma-asia-s-america-mena-row-regulatory-news-aug-2025/ 2025-09-03T13:01:24+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-europe-asia-and-row-regulatory-news-aug-2025/ 2025-09-09T10:53:33+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-asia-s-america-mena-row-regulatory-news-sept-2025/ 2025-10-08T09:20:39+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-sept-2025/ 2025-10-08T09:51:39+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-jan-2025/ 2025-10-27T04:03:20+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/the-impact-of-ai-on-medical-device-technology-and-certification/ 2025-10-27T09:13:40+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/2024-recap-medical-device-key-regulation-guidance-in-usa-eu-asia-and-row/ 2025-10-28T07:03:23+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-asia-and-row-regulatory-news-jan-2025/ 2025-10-28T08:32:10+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-asia-and-row-regulatory-news-sept-2024/ 2025-10-28T10:02:09+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-aug-2024/ 2025-10-28T10:31:02+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-and-row-regulatory-news-july-2024/ 2025-10-29T04:29:17+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-asia-and-row-regulatory-news-april-2024/ 2025-10-29T08:41:25+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-june-2024/ 2025-10-29T09:14:53+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/real-world-evidence-in-medical-device-to-support-regulatory-decisions/ 2025-10-29T09:54:38+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/adopting-a-life-cycle-approach-to-software-medical-devices-regulatory-guidelines-by-singapore-hsa/ 2025-10-29T10:03:22+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/wp-content/uploads/2024/04/Typical-illustration-of-an-AI-model.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-apr-2024/ 2025-10-30T03:49:09+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-nov-2023-vol-1/ 2025-10-30T03:54:34+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/modifications-to-medical-device-registration-in-mexico/ 2025-10-30T04:17:48+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blogs/usa-europe-med-device-regulatory-2023-news-updates-recap/ 2025-10-30T06:06:44+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/asia-row-biopharma-regulatory-2023-news-updates-recap/ 2025-10-31T08:44:15+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-and-row-regulatory-news-nov-2023/ 2025-10-31T08:58:03+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-asia-row-regulatory-news-oct-2023-vol-2/ 2025-10-31T09:27:02+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/recap-2023-key-medical-device-regulatory-highlights-in-asia-and-row/ 2025-10-31T10:42:29+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-and-row-regulatory-news-oct-2023/ 2025-11-03T09:45:29+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blogs/medical-devices-usa-europe-regulatory-news-nov-2023/ 2025-11-03T10:07:47+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/swissmedic-device-ivd-database-key-dates/ 2025-11-03T10:11:42+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-oct-2023-vol-1/ 2025-11-03T10:17:57+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blogs/medical-devices-usa-europe-regulatory-news-october-2023/ 2025-11-04T09:51:23+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-news-august-2023-2/ 2025-11-04T10:14:32+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-aug-2023-vol-1/ 2025-11-04T11:20:19+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-and-row-regulatory-news-sep-2023/ 2025-11-05T04:16:55+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-oct-2025/ 2025-11-06T05:11:56+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-asia-row-regulatory-news-sep-2023-vol-2/ 2025-11-13T04:45:29+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-sept-2023-vol-1/ 2025-11-13T05:10:02+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-regulatory-updates-roundup-aug-2022/ 2025-11-13T06:04:13+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-news-september-2023/ 2025-11-14T04:59:18+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-may-2023-vol-1/ 2025-11-14T05:39:29+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/pharma-biotech-asia-row-regulatory-news-june-2023-vol-2/ 2025-11-14T07:05:24+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-and-row-regulatory-news-june-2023/ 2025-11-14T09:03:48+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-june-2023-vol-1/ 2025-11-19T10:27:36+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/pharma-biotech-asia-row-regulatory-news-july-2023-vol-2/ 2025-11-19T11:32:02+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-and-row-regulatory-news-july-2023/ 2025-11-19T11:40:27+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-news-april-2023/ 2025-11-19T11:59:53+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-asia-row-regulatory-news-march-2023-vol-2/ 2025-11-20T04:54:33+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-and-row-regulatory-news-march-2023/ 2025-11-20T05:22:12+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-news-march-2023/ 2025-11-20T05:34:34+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-asia-row-regulatory-news-april-2023-vol-2/ 2025-11-20T06:00:45+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-and-row-regulatory-news-april-2023/ 2025-11-20T06:44:10+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-feb-2023-vol-1/ 2025-11-20T06:56:35+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/pharma-biotech-asia-row-regulatory-news-feb-2023-vol-2/ 2025-11-21T06:55:20+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-and-row-regulatory-news-feb-2023/ 2025-11-21T08:33:51+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-and-row-regulatory-news-jan-2023/ 2025-11-21T08:44:57+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-asia-row-regulatory-news-jan-2023-vol-2/ 2025-11-21T09:04:07+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-jan-2023-vol-1/ 2025-11-21T09:23:02+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/biopharma-europe-usa-and-asia-regulatory-news-dec-2022/ 2025-11-21T09:35:16+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-news-roundup-nov-2022/ 2025-11-21T09:46:51+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-regulatory-news-roundup-nov-2022/ 2025-11-21T09:58:24+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-updates-roundup-oct-2022/ 2025-11-21T10:06:47+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/mhra-guidance-for-medical-device-manufacturers-on-vigilance/ 2025-11-21T11:25:26+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-updates-roundup-august-2022/ 2025-11-21T11:32:11+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-updates-round-up-dec-2021/ 2025-11-21T11:50:59+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-regulatory-updates-roundup-nov-2021/ 2025-11-24T04:25:58+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-regulatory-updates-roundup-oct-2021/ 2025-11-24T04:39:52+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-regulatory-updates-roundup-oct-2022/ 2025-11-24T05:42:15+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-updates-round-up-oct-2021/ 2025-11-25T06:13:03+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-updates-round-up-sep-2021/ 2025-11-25T06:21:50+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-regulatory-updates-round-up-sep-2021/ 2025-11-25T06:31:46+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/safety-and-performance-ssp-of-class-c-and-d-ivds/ 2025-11-25T06:38:06+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/medical-devices-asia-regulatory-updates-round-up-aug-2021/ 2025-11-25T06:58:10+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-updates-round-up-aug-2021/ 2025-11-25T07:09:55+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-regulatory-updates-asia-round-up-jul-2021/ 2025-11-25T08:47:14+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-updates-round-up-jul-2021/ 2025-11-25T09:00:00+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/consumer-health-usa-europe-asia-row-regulatory-news-jan-2025/ 2025-11-25T11:33:24+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/2024-recap-biopharma-key-regulation-guidance-in-usa-eu-asia-and-row/ 2025-11-25T11:58:04+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/2024-recap-consumer-health-key-regulation-guidance-in-usa-eu-asia-and-row/ 2025-11-26T04:28:12+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/consumer-health-usa-uk-asia-row-regulatory-news-feb-2025/ 2025-11-26T04:33:23+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/consumer-health-usa-uk-asia-row-regulatory-news-oct-2024/ 2025-11-26T05:05:35+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-sept-2024/ 2025-11-26T05:34:51+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/consumer-health-usa-europe-asia-row-regulatory-news-sept-2024/ 2025-11-26T05:57:07+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-asia-and-row-regulatory-news-feb-2025/ 2025-11-26T06:15:14+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-asia-and-row-regulatory-news-oct-2024/ 2025-11-26T06:28:48+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/mhra-issues-transparency-for-machine-learning-and-medical-devices/ 2025-11-26T09:45:07+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/ehds-impact-wellness-apps-medical-devices/ 2025-11-26T09:49:33+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-asia-and-row-regulatory-news-june-2024/ 2025-11-26T09:55:34+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-asia-and-row-regulatory-news-july-2024/ 2025-11-26T11:31:16+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/consumer-health-usa-europe-asia-row-regulatory-news-july-2024/ 2025-11-26T11:38:06+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-asia-and-row-regulatory-news-may-2024/ 2025-11-26T11:44:30+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/consumer-health-usa/europe/asia/row-regulatory-news-may-2024/ 2025-11-26T11:52:39+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-may-2024/ 2025-11-27T04:12:15+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-asia-and-row-regulatory-news-mar-2024/ 2025-11-27T05:10:08+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/consumer-health-usa-europe-asia-row-regulatory-news-april-2024/ 2025-11-27T05:21:58+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/consumer-health-usa-europe-asia-row-regulatory-news-march-2024/ 2025-11-27T05:36:08+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-asia-and-row-regulatory-news-march-2024/ 2025-11-27T05:49:23+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-dec-2023-vol-1/ 2025-11-27T05:58:14+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/consumer-health-usa-europe-asia-row-regulatory-news-nov-2023/ 2025-11-27T06:14:51+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-news-dec-2023/ 2025-11-27T06:34:28+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-asia-and-row-regulatory-news-feb-2024/ 2025-11-27T07:51:20+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/consumer-health-usa-europe-asia-regulatory-news-feb-2024/ 2025-11-27T08:01:19+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/medical-devices-europe-asia-and-row-regulatory-news-feb-2024/ 2025-11-27T08:13:26+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/consumer-health-usa-europe-asia-row-regulatory-news-june-2024/ 2025-11-27T09:22:28+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-uk-asia-and-row-regulatory-news-aug-2024/ 2025-11-27T09:25:33+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blogs/consumer-health-usa-asia-row-regulatory-news-jan-2024/ 2025-11-28T04:14:28+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/usa-europe-biopharma-regulatory-2023-news-updates-recap/ 2025-11-28T04:27:42+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/challenges-benefits-and-future-trends-in-compliance-intelligence/ 2025-11-28T05:07:09+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/cosmetic-labeling-requirements-guidelines/ 2025-11-28T05:20:30+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg https://www.vistaar.ai/blog/consumer-health-usa-europe-asia-row-regulatory-news-oct-2023/ 2025-11-28T05:54:16+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/revised-gmp-guidelines-for-pharma-in-india/ 2025-11-28T06:03:06+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blogs/consumer-health-usa-and-asia-regulatory-news-sept-2023/ 2025-11-28T06:11:39+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/understanding-fda-labeling-regulations/ 2025-11-28T06:26:06+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/OTC.jpg https://www.vistaar.ai/blog/role-of-technology-in-regulatory-intelligence/ 2025-11-28T06:33:43+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Digital-Health.jpg https://www.vistaar.ai/blogs/pharma-biotech-asia-row-regulatory-news-nov-2023-vol-2/ 2025-11-28T06:49:55+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/avoiding-common-pitfalls-tips-for-complying-with-fda-cosmetics-regulations/ 2025-11-28T09:03:59+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-july-2023-vol-1/ 2025-11-28T09:12:54+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/the-future-of-fda-cosmetics-regulations-what-to-expect-in-the-coming-years/ 2025-12-01T05:48:47+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg https://www.vistaar.ai/blog/fda-regulations-for-medical-device-approval-in-usa/ 2025-12-01T06:07:54+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/mdr-regulations-impact-on-medical-devices/ 2025-12-01T06:16:38+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/ai-enabled-and-human-reviewed-regulatory-intelligence-tool/ 2025-12-01T06:24:32+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Digital-Health.jpg https://www.vistaar.ai/blog/pharma-biotech-usa-europe-regulatory-news-april-2023-vol-1/ 2025-12-01T06:35:09+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/fda-authority-over-cosmetics/ 2025-12-01T06:45:09+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg https://www.vistaar.ai/blog/medical-device-labelling-requirements/ 2025-12-01T06:51:00+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-device-and-restricted-hazardous-substances/ 2025-12-01T07:01:19+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/devices-asia-europe-and-usa-nov-regulatory-news/ 2025-12-01T08:44:27+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/eu-mdr-regulations/ 2025-12-01T08:48:15+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/global-regulatory-intelligence/ 2025-12-01T08:52:54+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/medical-devices-usa-europe-regulatory-news-july-2023/ 2025-12-01T09:30:11+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/what-pharma-companies-need-to-know-about-eu-mdr-regulations/ 2025-12-01T09:37:11+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/mhra-guidance-on-the-use-of-real-world-data-in-clinical-studies-to-support-regulatory-decisions/ 2025-12-02T09:06:41+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/procedural-aspects-for-the-consultation-to-the-european-medicines-agency-by-a-notified-body-on-companion-diagnostics/ 2025-12-02T09:10:49+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Diagnostics-min.jpg https://www.vistaar.ai/blog/medical-device-patient-information-leaflets-and-implant-cards/ 2025-12-02T09:23:14+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/control-of-nitrosamine-impurities-in-human-drugs/ 2025-12-02T09:41:19+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Food-1.jpg https://www.vistaar.ai/blog/categorization-and-registration-process-for-devices-in-eudamed/ 2025-12-02T09:49:59+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/guiding-principles-for-good-machine-learning-practice/ 2025-12-02T10:21:23+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/anti-infective-drug-products-for-the-pediatric-population-guidance-from-fda/ 2025-12-02T11:32:29+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/who-recommendations-for-screening-and-treatment-to-prevent-cervical-cancer/ 2025-12-02T11:39:26+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Diagnostics-min.jpg https://www.vistaar.ai/blog/color-additive-petitions-2/ 2025-12-02T12:00:41+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/guidance-on-premarket-submission-for-device-software-functions/ 2025-12-02T12:04:57+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/registration-of-drug-device-combination-products/ 2025-12-03T03:34:49+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/authorization-of-medical-devices-based-on-the-asean-harmonized-technical-requirements/ 2025-12-03T03:59:31+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/infusion-pumps-safety-assurance/ 2025-12-03T04:17:09+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/clinical-outcome-assessments-coas-in-medical-device-decision-making/ 2025-12-03T04:48:34+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/clinical-trial-management-guidelines-under-covid-19-europe/ 2025-12-03T04:53:57+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/adverse-reaction-reporting-guide-for-new-zealand/ 2025-12-03T05:05:34+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/regulatory-changes-for-software-based-medical-devices-in-australia/ 2025-12-03T05:24:25+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/medical-devices-regulatory-updates-august-volume-2/ 2025-12-03T05:38:15+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/samd-regulatory-landscape-in-the-us-and-europe/ 2025-12-03T05:52:12+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/clinical-and-performance-evaluation-under-eu-mdr-new-ce-market-rules/ 2025-12-03T06:06:21+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/ich-e6-good-clinical-practice-principles/ 2025-12-03T06:20:18+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/regulatory-intelligence-ri-unbolts-all-your-regulatory-challenges/ 2025-12-03T06:27:46+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/luxembourg-and-the-netherlands-benefit-from-the-eu-us-mutual-recognition-agreement-for-inspections/ 2025-12-03T06:47:15+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/usa-fda-confirms-the-guidelines-in-the-development-of-als-drugs/ 2025-12-03T06:49:03+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/OTC.jpg https://www.vistaar.ai/blog/south-africa-released-guidelines-how-to-submit-eoi-to-sahpra-on-who-collaborative-registration-procedure/ 2025-12-03T08:41:26+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/imdrf-offers-final-clinical-guidelines/ 2025-12-03T08:50:56+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/medical-device-post-market-surveillance/ 2025-12-03T08:58:19+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/an-overview-of-european-unique-device-identification-system/ 2025-12-03T09:05:30+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/usa-fda-drafts-guidance-on-bridging-data-for-combination-products/ 2025-12-03T09:13:47+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/famhp-new-legislative-measures-for-unavailable-medicines/ 2025-12-03T09:28:56+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/tga-regulatory-impact-statement-proposed-regulatory-scheme-for-personalised-medical-devices-including-3d-printed-devices/ 2025-12-03T09:34:50+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/usa-and-europe-looking-ahead-to-2020/ 2025-12-03T09:46:57+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/usa-cdrh-drafts-guidance-on-contact-lenses-performance-criteria-to-support-510ks/ 2025-12-03T10:14:40+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/real-world-data-and-real-world-evidence-to-support-regulatory-decision-making-for-drug-and-biological-products-fda-draft-guidance/ 2025-12-03T11:59:21+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Diagnostics-min.jpg https://www.vistaar.ai/blog/color-additive-petitions/ 2025-12-04T03:58:35+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/eu-ec-offers-new-site-suitability-template-under-incoming-clinical-trial-regulation/ 2025-12-05T03:49:33+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Standards-min.jpg https://www.vistaar.ai/blog/europe-medical-device-incident-reporting/ 2025-12-05T04:32:06+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/unique-device-identification-system/ 2025-12-09T10:25:50+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/pharma-asia-s-america-mena-row-regulatory-news-oct-2025/ 2026-01-09T12:58:39+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/regulatory-intelligence-database-for-global-compliance-and-strategic-decision-making/ 2026-01-12T04:51:14+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Biopharma-min.jpg https://www.vistaar.ai/blog/navigate-global-compliance-with-a-medical-device-regulatory-intelligence-registration-database/ 2026-01-12T05:35:35+00:00 https://www.vistaar.ai/wp-content/uploads/2024/01/Device-min.jpg https://www.vistaar.ai/blog/a-guide-to-regulatory-compliance-and-requirements-in-consumer-healthcare/ 2026-01-12T05:35:41+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Dietary-Supplements.jpg https://www.vistaar.ai/blog/align-regulatory-requirements-with-project-management-best-practices/ 2026-02-12T08:15:09+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/regulatory-change-management-why-businesses-need-smarter-compliance-monitoringblogs/ 2026-05-28T07:50:29+00:00 https://www.vistaar.ai/wp-content/uploads/2024/11/Regulatory-Intelligence.jpg https://www.vistaar.ai/blog/cosmetic-regulations-database-global-compliance/ 2026-07-07T05:52:57+00:00 https://www.vistaar.ai/wp-content/uploads/2024/02/Cosmetics.jpg